Annotate Genomics

An innovative organization dedicated to improving the lives and health of people through precision medicine and genomic oncology. Annotate Genomics is a world-leading cancer solutions specialist provider. We offer precision medicine services in Taiwan, Singapore, South Africa and the rest of Africa. We combine expertise in precision medicine, tumor biology, cancer genomics, and bioinformatics to provide treatment guidelines for solid tumors, risk-prediction for relapse, drug resistance, as well as cancer monitoring, risk assessment, and immunotherapy evaluation. Through our cutting-edge next-generation sequencing (NGS) platform, expert bioinformatic analysis, and comprehensive oncology sequencing, we are dedicated to changing every cancer patient’s journey by turning genetic information into actionable solutions. Our NGS platform coupled with sophisticated bioinformatics tools and curated proprietary databases enable us to deliver reliable interpretation and recommendations for clinical and research purposes. We use novel data visualization technologies to make genomic information understandable and accessible to patients and clinicians. Our clinical services range from cancer screening, prevention, early detection, treatment recommendation and disease monitoring. Our genomic assays offer comprehensive cancer genomic profiling and treatment options for patients with cancer; and provide insights to biomarker discovery and patient stratification for clinical trials. Embrace the future of Precision Medicine. Annotate Genomics, your partner in health.